AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionTalbot Financial, LLC
Latest Disclosed Ownership127,106 shares
Latest Disclosed Value $ 27,644,176
Talbot Financial, LLC reports 4.41% increase in ownership of 4AB / AbbVie Inc.

On April 10, 2026 - Talbot Financial, LLC filed a 13F-HR form disclosing ownership of 127,106 shares of AbbVie Inc. (BG:4AB) valued at $27,644,176 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 121,735 shares of AbbVie Inc.. This represents a change in shares of 4.41% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F ABBVIE COM 00287Y109 127,106 5,371 4.41 27,644 -0.61 2.3232
2026-01-21 2025-12-31 13F ABBVIE COM 00287Y109 121,735 851 0.70 27,815 -0.62 2.2897
2025-10-08 2025-09-30 13F ABBVIE COM 00287Y109 120,884 4,537 3.90 27,989 29.60 2.3687
2025-07-22 2025-06-30 13F ABBVIE COM 00287Y109 116,347 22,115 23.47 21,596 9.39 2.0444
2025-04-09 2025-03-31 13F ABBVIE COM 00287Y109 94,232 -2,277 -2.36 19,744 15.13 2.4733
2025-01-13 2024-12-31 13F ABBVIE COM 00287Y109 96,509 4,503 4.89 17,150 -5.61 2.0396
2024-10-08 2024-09-30 13F ABBVIE COM 00287Y109 92,006 1,344 1.48 18,169 16.84 2.2119
2024-07-11 2024-06-30 13F ABBVIE COM 00287Y109 90,662 1,168 1.31 15,550 -4.58 2.0071
2024-04-18 2024-03-31 13F ABBVIE COM 00287Y109 89,494 954 1.08 16,297 18.77 2.1804
2024-01-11 2023-12-31 13F ABBVIE COM 00287Y109 88,540 4,661 5.56 13,721 9.75 2.0644
2023-10-24 2023-09-30 13F ABBVIE COM 00287Y109 83,879 1,989 2.43 12,503 13.31 2.1796
2023-07-28 2023-06-30 13F ABBVIE COM 00287Y109 81,890 589 0.72 11,033 -14.84 1.8764
2023-05-08 2023-03-31 13F ABBVIE COM 00287Y109 81,301 -15,797 -16.27 12,957 -17.44 2.4083
2023-02-16 2022-12-31 13F ABBVIE COM 00287Y109 97,098 97,098 15,692 3.2282
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.